Espoo, Finland, 20 November 2020 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, announces that it will present at the PCR London Valves E-Course running from 22-24 November 2020.
Kari Kervinen, MD, PhD, Oulu University Hospital, Finland, and clinical advisor to Medtentia, will present Treatment of MR: physiological annulus downsizing with an innovative helix ring. Long-term results with surgical model and mid-term results with transcatheter model as part of the Best Innovations session on 24 November at 13.00-13.45 CET.
The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. Its activities cover a large spectrum, from the organisation of annual courses in Europe, Asia, Africa and the Middle East, to editing a scientific journal, publishing textbooks as well as providing training sessions and online courses on thematic subjects. Courses are based on themes like Coronary Interventions, Hypertension and Stroke, Peripheral Interventions, Valvular Disease and Heart Failure.
The PCR Valves E-Course is three days of interactive learning with a global outreach. Over 6,300+ e-Learners will join the innovative digital initiative from the comfort of their home or office. The highly practical programme will cover the three valves – aortic, mitral and tricuspid – for the benefit of Heart Valve Team members with all levels of experience.